Episode

VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)

Podcast

PsychRounds: The Psychiatry Podcast

Published

Mar 21, 2026

Duration seconds

1039

Processing state

not_requested

Canonical source

https://podcasters.spotify.com/pod/show/psychrounds/episodes/VMAT2-Inhibitors-Valbenazine-Ingrezza-and-Deutetrabenazine-Austedo-e3g8odb

Audio

https://anchor.fm/s/eb936048/podcast/play/116727659/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-2-11%2F419751627-44100-2-e2a85ebd5c645.m4a

JSON

/v1/public/podcasts/psychrounds-the-psychiatry-podcast-6714703/episodes/vmat2-inhibitors-valbenazine-ingrezza-and-deutetrabenazine-austedo

Markdown

/podcast/psychrounds-the-psychiatry-podcast-6714703/vmat2-inhibitors-valbenazine-ingrezza-and-deutetrabenazine-austedo.md

Actions

• POST https://stenobird.com/v1/public/podcasts/psychrounds-the-psychiatry-podcast-6714703/episodes/vmat2-inhibitors-valbenazine-ingrezza-and-deutetrabenazine-austedo/transcription-requests
  Idempotently request low-priority transcript generation for this episode.
• GET https://stenobird.com/podcast/psychrounds-the-psychiatry-podcast-6714703/vmat2-inhibitors-valbenazine-ingrezza-and-deutetrabenazine-austedo.md
  Read the agent-friendly Markdown representation of this episode resource.

Summary

Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo). References: https://pubmed.ncbi.nlm.nih.gov/41626799/ https://www.ncbi.nlm.nih.gov/books/NBK548187/ https://pubmed.ncbi.nlm.nih.gov/41626799/